Collectively, these findings demonstrate that muscle expression and circulating levels of Musclin are increased in cases of obesity and diabetes in both humans and mice, and that Musclin might play a pivotal role in the pathogenesis of obesity and its associated metabolic disorders through crosstalk between muscles and other metabolic tissues. This evidence concerns the gene OSTN and obesity due to melanocortin 4 receptor deficiency.